Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Brian Newman is Director at Colgate-Palmolive. OQRO lists 9 transactions filed with the SEC under this name, the latest on Oct 3, 2026, each linked to the official Form 4.
Director
Disclosures on record
9
Companies involved
2
Brian Newman has no open-market purchase on record since 2023. Sales in 1 of the 4 years since 2023.
Brian Newman reported 0 open-market purchases and 1 sale since 2023; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2023 | — | $3.47M1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Colgate-PalmoliveCL
6 disclosures · Jan 2026 – Oct 2026
Oct 1, 2026214disclosed Oct 3
DetailsOfficial recordJul 1, 2026209disclosed Jul 2
DetailsOfficial recordMay 11, 20262,075disclosed May 13
DetailsOfficial recordMay 11, 20262,424disclosed May 13
DetailsOfficial recordApr 1, 2026210disclosed Apr 3
DetailsOfficial recordJan 2, 2026238disclosed Jan 6
DetailsOfficial recordCVS HealthCVS
3 disclosures · Apr 2026 – Jun 2026
May 31, 20262,478disclosed Jun 1
DetailsOfficial recordMar 31, 202619Kdisclosed Apr 2
DetailsOfficial recordMar 31, 2026126Kdisclosed Apr 2
DetailsOfficial recordAs of the latest filing on , Brian Newman reported holding 8,058 shares of Colgate-Palmolive (CL), worth about $797K at the last close of $99 (Nov 18, 2026). Holdings are also on file at CVS Health (CVS); together they are worth about $1.04M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Colgate-Palmolive CL | 8,058 | 8,058 direct | $99 | $797K | Oct 1, 2026 |
| CVS Health CVS | 3,008 | 3,008 direct | $81 | $245K | May 31, 2026 |
Is this Brian Newman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Brian Newman reported 0 open-market purchases and 1 sale here, 2023.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Oct 1, 2026, Brian Newman reported holding 8,058 shares of Colgate-Palmolive (CL). At the last close of $99 on Nov 18, 2026, that is about $797K. This is the stake disclosed in filings, not a net worth.
No public filing gives Brian Newman's net worth. What SEC Form 4 shows is the stock stake: 8,058 shares of Colgate-Palmolive (CL), about $797K at the last close, plus holdings in 1 other company, about $1.04M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Brian Newman has no open-market purchase on record since 2023. Sales in 1 of the 4 years since 2023.
In SEC filings since 2023: no open-market purchase is on record; the latest open-market sale is from 2023.
UPS (UPS), from 2023 to 2023: 0 purchases and 1 sale.